Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0AZVIP
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Trastuzumab-G-15
|
|||||
| Synonyms |
Trastuzumab G-15
Click to Show/Hide
|
|||||
| Organization |
Pierre Fabre SA.
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 2 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
4
|
|||||
| Antibody Name |
Trastuzumab
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (HER2)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Trastuzumab-G-15F-13
|
|||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||
